Hartland & Co »

Zentalis Pharmaceuticals shares owned by Hartland & Co

Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by Hartland & Co from 13F filings

Historical chart of Hartland & Co investment in Zentalis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Zentalis Pharmaceuticals held by Hartland & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zentalis Pharmaceuticals by Hartland & Co

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.7k 1.1k 1.51
2025-06-30 $2.4k 2.1k 1.16

More positions owned by Hartland & Co

Vanguard Index Fds S&p 500 Etf Shs Put Option (Principal) (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Rus 1000 Grw Etf (IWF)
Apple (AAPL)
Vanguard Index Fds Mid Cap Etf (VO)
Microsoft Corporation (MSFT)
Vanguard Index Fds Small Cp Etf (VB)
Vanguard Index Fds Value Etf (VTV)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
NVIDIA Corporation (NVDA)
Wisdomtree Tr Us Largecap Divd (DLN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)

View all positions for Hartland & Co

Top funds holding Zentalis Pharmaceuticals

Matrix Capital Management Company
Vanguard Group
Acadian Asset Management
Renaissance Technologies
Citadel Advisors
Tang Capital Management
Two Sigma Advisers
D. E. Shaw & Co
Two Sigma Investments
Decheng Capital
BlackRock
Balyasny Asset Management
Morgan Stanley
GSA Capital Partners
PRIMECAP Management Company

View all funds holding Zentalis Pharmaceuticals